ETR vs STRO
Entergy Corporation (ETR) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ETR and STRO stock pages for the full models.
Not investment advice.